BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31898667)

  • 1. Regulation of HMGA2 and KRAS genes in epithelial ovarian cancer by miRNA hsa-let-7d-3p.
    Gunel T; Dogan B; Gumusoglu E; Hosseini MK; Topuz S; Aydinli K
    J Cancer Res Ther; 2019; 15(6):1321-1327. PubMed ID: 31898667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian cancer cells in vitro].
    Ye H; Chen J; Huang X; Guo A; Hao P
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1752-7. PubMed ID: 23268403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the circulating microRNA hsa-let-7d-3p as a potential new biomarker for sepsis in human subjects.
    Zhang Z; Luo H; Li C; Liang Z
    Eur J Med Res; 2022 Jul; 27(1):137. PubMed ID: 35907902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel microRNAs expression of patients with chemotherapy drug-resistant and chemotherapy-sensitive epithelial ovarian cancer.
    Liu L; Zou J; Wang Q; Yin FQ; Zhang W; Li L
    Tumour Biol; 2014 Aug; 35(8):7713-7. PubMed ID: 24805828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer.
    García-Vázquez R; Gallardo Rincón D; Ruiz-García E; Meneses García A; Hernández De La Cruz ON; Astudillo-De La Vega H; Isla-Ortiz D; Marchat LA; Salinas-Vera YM; Carlos-Reyes Á; López-González S; Ramos-Payan R; López-Camarillo C
    Oncol Rep; 2018 Jun; 39(6):3086-3094. PubMed ID: 29658612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells.
    Choo KB; Soon YL; Nguyen PN; Hiew MS; Huang CJ
    J Biomed Sci; 2014 Oct; 21(1):95. PubMed ID: 25287248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Let-7d-3p Contributes to Cardiac Protection via Targeting HMGA2.
    Wong LL; Saw EL; Lim JY; Zhou Y; Richards AM; Wang P
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p.
    Wang C; Qi S; Xie C; Li C; Wang P; Liu D
    J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
    Li S; Hao H; Li R; Guo S
    Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
    Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
    Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression.
    Wang Y; Le Y; Xue JY; Zheng ZJ; Xue YM
    Biochem Biophys Res Commun; 2016 Oct; 479(4):676-682. PubMed ID: 27693697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
    Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
    Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction.
    Kumar V; Gupta S; Varma K; Chaurasia A; Sachan M
    J Gynecol Oncol; 2022 Jul; 33(4):e49. PubMed ID: 35557032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of miRNA let-7a and HMGA2 and Diagnostic Value of Serum miRNA let-7a Level in Pancreatic Cancer].
    Mao XB; Sheng T; Zhuang LP; Wu CK; Zhao GG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):540-545. PubMed ID: 32691564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer.
    Gumusoglu-Acar E; Gunel T; Hosseini MK; Dogan B; Tekarslan EE; Gurdamar B; Cevik N; Sezerman U; Topuz S; Aydinli K
    Oncol Lett; 2023 Apr; 25(4):142. PubMed ID: 36909377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer.
    Biamonte F; Santamaria G; Sacco A; Perrone FM; Di Cello A; Battaglia AM; Salatino A; Di Vito A; Aversa I; Venturella R; Zullo F; Costanzo F
    Sci Rep; 2019 Apr; 9(1):5668. PubMed ID: 30952937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.